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Abstract The amyloid precursor protein (APP) is part of
a larger gene family, which has been found to form homo-
or heterotypic complexes with its homologues, whereby the
exact molecular mechanism and origin of dimer formation
remains elusive. In order to assess the cellular location of
dimerization, we have generated a cell culture model sys-
tem in CHO-K1 cells, stably expressing human APP,
harboring dilysine-based organelle sorting motifs [KKAA-
endoplasmic reticulum (ER); KKFF-Golgi], accomplishing
retention within early secretory compartments. We show
that APP exists as disulﬁde-bonded dimers upon ER
retention after it was isolated from cells, and analyzed by
SDS-polyacrylamide gel electrophoresis under non-reduc-
ing conditions. In contrast, strong denaturing and reducing
conditions, or deletion of the E1 domain, resulted in the
disappearance of those dimers. Thus we provide ﬁrst evi-
dence that a fraction of APP can associate via
intermolecular disulﬁde bonds, likely generated between
cysteines located in the extracellular E1 domain. We par-
ticularly visualize APP dimerization itself and identiﬁed
the ER as subcellular compartment of its origin using
biochemical or split GFP approaches. Interestingly, we also
found that minor amounts of SDS-resistant APP dimers
were located to the cell surface, revealing that once gen-
erated in the oxidative environment of the ER, dimers
remained stably associated during transport. In addition,
we show that APP isoforms encompassing the Kunitz-type
protease inhibitor (KPI) domain exhibit a strongly reduced
ability to form cis-directed dimers in the ER, whereas
trans-mediated cell aggregation of Drosophila Schneider
S2-cells was isoform independent. Thus, suggesting that
steric properties of KPI-APP might be the cause for weaker
cis-interaction in the ER, compared to APP695. Finally, we
provide evidence that APP/APLP1 heterointeractions are
likewise initiated in the ER.
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Introduction
The amyloid precursor protein (APP) is a type I trans-
membrane glycoprotein that is found in all cell types
throughout the body, including neurons. Its overall
structure resembles a cell surface receptor with a large
ectodomain, a single transmembrane domain and a short
cytoplasmic tail [1, 2] that may be important for signal
transduction and transcription [1, 3]. Proteolytic APP
cleavage leads to the production of the b-amyloid peptide
(Ab), which is the major constituent of the amyloid core
of senile plaques, found in the brains of patients with
Alzheimer’s disease (AD). APP is expressed in three
different major isoforms generated by alternative splicing,
consisting of 695, 751, or 770 amino acids. The larger two
isoforms contain an additional 56 amino acid domain in
the middle of the APP sequence, which is structurally and
functionally related to Kunitz-type serine protease inhib-
itors (KPI) [4, 5]. Two paralogues of APP have been
identiﬁed in mammals, named amyloid precursor like
proteins, APLP1 and APLP2 [6]. The redundancy of APP
and APLPs is reﬂected in an analogous protein domain
structure and a similar proteolytic processing [7], although
the Ab region is unique to APP [8–10]. On the extracel-
lular side, a cysteine-rich growth factor-like domain
(GFLD) with heparin binding properties (HBD) is fol-
lowed by zinc and copper binding domains (Zn/Cu-BD)
referred to as the E1 domain. The E1 domain is then
followed by an acidic stretch, rich in aspartic acid and
glutamic acid, and the KPI domain, which is not present
in APP695 and APLP1. The E2 region consists of another
HBD/GFLD and a carbohydrate domain, containing the
N-glycosylation sites of the ectodomain [7]. Although
APP has been the subject of much study since its iden-
tiﬁcation, its physiological function remains largely
undetermined. Recently, a new research direction has
begun to emerge, intending to elucidate the mechanisms
and importance of APP dimerization. However, there is
accumulating evidence from biochemical and structural
data that APP can form homodimers [8–10] as well as
heterodimers with its paralogues APLP1 and APLP2 [9].
Various experimental approaches have been attempted to
visualize dimerization between APP family proteins. The
ﬁrst studies demonstrated the existence of APP–APP
interactions at the cell surface, by covalently cross-linking
APP at the plasma membrane [8, 9]. Other initial studies
showed that a disulﬁde-bridged loop, encompassing resi-
dues 91–111, seemed to be required and necessary for the
stabilization of APP homodimers [10, 11], whereas APP
interaction was gradually diminished by adding a small
peptide mimicking the loop region (loop peptide) [10].
Interestingly, this loop peptide interacted via hydrophobic
forces with the APP E1 domain and decreased the gen-
eration of sAPPb as well as Ab40 and Ab42 when the
synthetic peptide was added to APP-expressing cells,
raising the possibility that APP monomer/dimer status
somewhat might affect Ab generation and could play a
role in the pathology of AD. In this respect, recent reports
have also implicated the APP transmembrane region as a
site for cis-dimerization. Introduction of a cysteine
mutation in the juxtamembrane/transmembrane (JM/TM)
region of APP has been shown to form constitutive dimers
by disulﬁde bridging within the Ab domain, suggesting
close proximity and interaction of the APP TM region [8].
Moreover, the APP transmembrane domain efﬁciently
dimerized in a bacterial assay [12], where APP contains
three consecutive glycine-xxx-glycine (GxxxG) motifs
[12–15], one embedded within the Ab sequence. There-
fore, this motif was investigated in depth due to its
putative impact on Ab generation. It has been shown that
mutations of the glycine residues in the GxxxG motifs to
alanine residues attenuate TM dimerization and result in a
marked reduction in the processing of APP, and the pro-
duction of toxic Ab42 [12, 15]. Similarly, speciﬁc
gamma-secretase modulators (GSM) were recently dem-
onstrated to lower Ab levels, by directly interfering with
APP TMS dimerization [16]. However, chemically
induced dimerization of APP led to decreased APP pro-
cessing and reduced Ab levels [17], likewise
heterodimerization with its homologues APLP1 and
APLP2 was also shown to diminish overall Ab formation
[11]. Other studies have focused more on the extracellular
part of APP, and demonstrated by aggregation assays that
the APP family members are able to form both homo-and
heterotypic complexes in cis-and trans-cellular fashion
and that this interaction promoted cell adhesion [9],
1354 S. Isbert et al.
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was also identiﬁed as a major interaction interface for
cis-directed dimerization using deletion constructs in
co-immunoprecipitations [9], or FRET analysis [11].
Alternatively, it has been proposed by crystallographic
and X-ray structure modeling that the E2 region can
reversibly dimerize in solution in an antiparallel orienta-
tion [18], whereas other conformational studies indicated
that the APP ectodomain is monomeric in solution, but
forms a complex with extracellular matrix components,
such as heparin, which may also regulate dimerization
[19].
Despite accumulating data towards APP dimerization,
the physiological signiﬁcance and subcellular localiza-
tion of its generation are still under debate. Preliminary
evidence that APP oligomerization might occur as early
as in the ER was obtained when chemically cross-
linked [
35S]sulfate-labeled APP migrated slower than
[
35S]methionine-labeled, after being monomerized by
reducing agents, suggesting that dimerization was ini-
tiated before maturation of N-linked oligosaccharides or
tyrosine sulfation [8]. Nevertheless, the precise mode of
dimerization remained somewhat elusive, though pre-
dominantly hydrophobic interactions between the TM-
or ectodomains have been suggested so far [9–12].
Interestingly, few studies have shown that e.g., C99
[14] or myc- and GFP-tagged APP migrates as a dimer
on SDS-polyacrylamide gels [8], suggesting that stron-
ger interactions might also play a role in APP
dimerization.
To assess the putative dimerization potential of APP in
different cellular compartments, we made use of well-
described cytosolic dilysine-based motifs, designated as
KKAA or KKFF, which are critical for endoplasmic
reticulum (ER) localization, exit, or retrieval of type I
membrane proteins [20–22]. We have employed a cell
culture model system in CHO-K1 cells, stably over-
expressing APP chimeric proteins, tagged with respective
C-terminal doublelysine retention motifs. Using a variety
of biochemical techniques, we could successfully demon-
strate in a highly reproducible manner that chimeric
APP695, containing the retention signals, was effectively
retained within early secretory compartments. Addition-
ally, we obtained high amounts of SDS-stable APP695
homodimers when APP was localized to the ER, but we
also recovered minor quantities at the plasma membrane,
which dissociate upon strong reducing conditions, sug-
gesting the participation of disulﬁde bonds. Interestingly,
the cis-dimerization capacity of APP within the same cell
differed between isoforms, whereas trans-cellular dimer-
ization was isoform independent. Finally, we could show
that APP and APLP1 also form SDS-resistant heterodi-
mers, likely initiated in the ER.
Materials and methods
Cell lines and transfections
All Chinese hamster ovary (CHO-K1) cell lines were
grown in Alpha Minimum Essential Medium (a-MEM)
supplemented with 10% fetal bovine serum, 1 mM sodium
pyruvate, and 100 U/ml penicillin/streptomycin. All APP
constructs were inserted into the retroviral expression
vector pLBCX. For generation of stably expressing cells,
virus production was induced by double transfection of
pLBCX with pVSV-G at a 1:1 ratio into the packaging cell
line GP2-293 (Clontech, Mountain View, CA, USA) using
the calcium phosphate transfection method. The medium
was changed after 48 h and viruses were collected for
another 24 h. After infection with recombinant viruses in
the presence of 5 lg/ml polybrene for 24 h, CHO-K1 cells
were selected with 6 lg/ml blasticidin (Invitrogen, Carls-
bad, CA, USA). Stable pools with comparable expression
levels were analyzed in further experiments. Co-transfec-
tions of stably overexpressing CHO-K1 cells with other
plasmid DNAs were performed using Lipofectamine
TM
2000 (Invitrogen, Carlsbad, CA, USA), according to the
manufacturers’ protocol.
cDNA constructs and cloning
The plasmids pLHCX-APP695wt, pLHCX-APP770wt, and
pcDNA3-APP751 [23] were used as templates to subclone
APP sequences into the pLBCX vector backbone with a
50HindIII and 30ClaI restriction site containing an addi-
tional 30 myc-epitope, using the following fwd primer:
50-CCCAAGCTTATGCTGCCCGGTTTGGCACTGCTC-3;
and rev primer: 50-CCATCGATTTAGTTCTGCATCTG
CTCAAAGAACTT-30. The same plasmids were used to
add the KKAA (APP ER) or KKFF (APP Golgi) retention
motifs to the very C-terminus of APP constructs following
the myc-tag, using the rev primer 50-CCATCGATTTA
GGCGGCCTTCTTATGGTGATGGTGATGATGACCGG
TATGCATATT-30, for KKAA and 50CCATCGATTTA
GGCGGCTTTTTTATGGTGATGGTGATGATGACCGG
TATGCATATT-30 for KKFF, each containing a ClaI site.
To attach an HA epitope to the C-terminus of all three
different APP isoforms, the aforementioned cDNAs were
used as templates with standard PCR techniques and the
following primers: fwd 50-CCCAAGCTTATGCTGCCCG
GTTTGGCACTGCTCCT-30, introducing a HindIII site,
rev 50- CCATCGATTTAAGCGTAATCTGGAACATCG
TATGGGTAGTTCTGCATCTGCTCAAAGAACTTGTA
GGTTGGATT-30. The KKAA motif was subsequently
attached to the HA tag at the C-terminus with the following
rev primer: 50- CCATCGATTTAGGCGGCCTTCTTAGC
GTAATCTGGAACATCGTATGGGTAG TTCTGCATCT
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truncated APP695DE1 in pcDNA3 was described else-
where [11]. The cDNA was also subcloned into pLBCX
and ampliﬁed by standard PCR techniques with the same
primers as designated above, to attach a myc-epitope alone,
or followed by an additional KKAA retention motif. All
PCR products were digested with HindIII 9 ClaI and
ligated into pLBCX retroviral expression vector. The
cDNA of human APLP1 in the peak8 expression vector
was kindly provided by Stefan F. Lichtenthaler (Munich,
Germany). The coding sequence was ampliﬁed by PCR to
add HindIII and ClaI restriction sites, using following
primers: fwd 50 CCCAAGCTTTAATGGGGCCCGCCA
GCCCCGCTGCTC-30 and rev 50-CCATCGATTTAGGG
TCGTTCCTCCAGGAAGCGGTAA-30to subclone into
pLBCX. To generate the cysteine mutants APP695 K28C
and APP770 K28C, containing a C-terminal myc-epitope,
APP695wt pLBCX and APP770wt pLBCX were used as
templates and the mutation was introduced by an overlap
extensionPCRstrategy.Twomutagenicprimers,containing
the desired mismatch K28C, completely complementary to
each other were generated as follows: fwd 50- GTGGGTTC
AAACTGTGGTGCAATCATTG-30 and rev 50-CAATGA
TTGCACCACAGTTTGAACCCAC-30. Each primer was
used in a separate reaction with an outer ﬂanking primer
(50HindIII and 30ClaI, see above), designed to one end of the
region of interest, which were used for all other APP con-
structs so far. In a third PCR, both halves of the construct,
which are partly complementary, prime off each other and
give the full-length product, comprising the desired muta-
tion. The APP695 ER 98-105ser mutant was generated with
the same method as described before, using the following
mutagenic primers: fwd 50-CCAGTGACCATCCAGAAC
TGGTCCAAGCGGGGCCGCAAGCAGTCCAAGACCCA
TCCCCACTTTGT-30;r e v5 0-ACAAAGTGGGGATGGGT
CTTGGACTGCTTGCGGCCCCGCTTGGACCAGTTCTG
GATGGTCACTGG-30. All generated constructs were
checked by sequencing. Cloning of NT HA APP695 CT Split
GFP constructs 1–10 and 11. Generation of plasmid NT HA
APP695 CT Split GFP 1–10: for the ﬁrst PCR, template
APP695 NT HA in pcDNA3.1 [9] was ampliﬁed with forward
primer sAPP-3 (starts at position 1681 in the APP695 ORF)
50-GAAGTTGAGCCTGTTGATGCC-30 and reverse primer:
50-GCTATGACG CGTGTTCTGCATCTGCTC-30, introduc-
ing a MluI restriction site. The resulting PCR product was
digestedwithEcoRIandMluItoobtaina293-bpfragment.For
the second PCR, template GFP 1–10 [24] was ampliﬁed with
forward primer 50-GCGATGACGCGTGGTGGTTCGGGTG
GTATGTCCAAAGGAGAAG-30 containing a MluI site and
reverse primer 50-GCCCGCCTCGAGTCATGTTCCTTTTT
CATTTGG-30, including an XhoI site. The resulting PCR
product was digested with MluI and XhoI. The two PCR
fragmentswereligatedintovectorpcDNA3.1? containingthe
30 UTR cassette of APP (XhoI/XbaI) [17], using the enzyme
sites for EcoRI and XhoI. To add in the 50 end of the APP
fragment, plasmid APP695 NT HA [9] was digested with
EcoRI. The resulting 1,900-bp fragment including the HA tag
was ligated via EcoRI in the above-mentioned new plasmid.
CloningofNTHAAPP695CTSplitGFP11wasperformedin
analogy to NT HA APP695 CT Split GFP 1–10. Only the
second PCR product was generated differently: Template Split
GFP 11 [24] was ampliﬁed with forward primer 50-CTATGA
CGCGTTCGGGTGGTGGTGGTTCGGGTGGTGGTGG
T-30, including a MluI site and reverse primer 50-CTATGC
TCGAGTTAGGTGATGCCGGGGCGTTC-30, introducing
anXhoIsite.Theresulting100-bpPCRproductwasdigested
with MluI/XhoI.
Antibodies
The monoclonal antibody 9E10 recognizing the myc-epi-
tope was generated from a mouse hybridoma cell line and
used to detect all overexpressed APP constructs in stable
CHO-K1 cell lines. Optionally, the polyclonal CT15 [23]
antibody was used, raised against the last 15 amino acids of
APP. Detection of transiently transfected human APP iso-
forms, containing a C-terminal HA epitope, was carried out
with polyclonal rat HA antibody purchased from Roche.
Human APLP1 was detected with C-terminal, polyclonal
171615, purchased from Calbiochem. Monoclonal a-Tubulin
antibody was obtained from Sigma-Aldrich. Secondary
HRP-conjugated goat antibodies against mouse and rabbit
were purchased from Jackson Lab, Maine (USA). NT HA
APP695 CT Split GFP 1–10 and NT HA APP695 CT Split
GFP 11 constructs were analyzed via Western blotting for
APP full-length with monoclonal N-terminal APP antibody
22C11 (Millipore), or APP CTFs with antibody APP CT
(clone Y188, rabbit monoclonal, Epitomics). APP-GFP
fusions were detected with monoclonal GFP antibody
(SC-9996, Santa Cruz).
Western blotting and co-immunoprecipitations
Cells were washed with cold 19 PBS, scraped off culture
dishes and lysed in NP-40 lysis buffer (500 mM Tris, pH
7.4, 150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40,
0.02% sodium azide), plus complete protease inhibitors
(Roche). Debris were pelleted by centrifugation at
20,000 9 g for 20 min at 4C in a microcentrifuge. Equal
amounts of total protein, determined by BCA protein assay
(Pierce Chemicals, Rockford, IL, USA), were used for
lysate analysis. Aliquots of CHO-K1 cell lysates, stably
overexpressing APP constructs, were either incubated with
SDS sample loading buffer (0.625 M Tris-HCl, pH 6.8,
2% w/v SDS, 10% w/v glycerol, 5% b-mercaptoethanol)
and directly subjected to SDS-PAGE, or heated at indicated
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123temperatures. Alternatively, samples were incubated with
sample buffer without b-mercaptoethanol and heat dena-
tured for 10 min. Proteins were electrophoresed on 4–12%
NuPage (Novex
, Invitrogen) gradient gels and transferred
onto nitrocellulose membranes (Millipore, Bedford, MA,
USA). Non-speciﬁc binding to membranes was blocked 1 h
with 5% non-fat dry milk in TBS containing 0.01% Tween-
20 (Roth, Germany), before incubation with the appropri-
ate primary and secondary antibodies. Proteins were
detected using enhanced chemiluminescence (Millipore)
by using the LAS-3,000mini (Fujiﬁlm, Duesseldorf, Ger-
many). For co-immunoprecipitation, cells were lysed in
NP-40 buffer and equal amounts of total lysates (250 lg)
were precipitated using protein A agarose beads (Invitro-
gen), with either 9E10 antibody for APP, or 171615 for
APLP1 (Calbiochem). Beads were collected by low speed
centrifugation and washed four times with lysis buffer.
Bound proteins were eluted from beads with 30 ll29
SDS sample buffer containing BME and analyzed by
Western-blot and appropriate primary and secondary anti-
bodies. Immunoreactive bands were visualized using an
ECL (enhanced chemiluminescence) system (Millipore), as
above.
Cell surface-biotinylation
To examine surface levels of APP, cells were grown in
60-mm dishes to 90% conﬂuency, and rinsed three times
with ice-cold PBS. Cell surface proteins were biotinylated
with 0.5 mg/ml Sulfo-NHS-LC–LC-Biotin (Pierce) in ice-
cold PBS for 40 min at 4C. The biotin solution was
exchanged once after 20 min. Cells were washed four
times with ice-cold PBS containing 50 mM NH4Cl to
quench unconjugated biotin and lysed in NP-40 buffer.
Equal amounts of proteins were incubated with NeutrA-
vidin Agarose resin (Pierce) at 4C overnight. Biotinylated
proteins were recovered by boiling in 2 9 SDS sample
buffer for 5 min and separated on 4–12% NuPage (Novex
,
Invitrogen).
Metabolic labeling and immunoprecipitation of APP
CHO-K1 cells, stably overexpressing APP695wt or
APP695 KKAA were plated in six-well culture dishes.
After 24 h, the cultures were pulse-labeled for 15 min at
37C with 1 ml methionine-free DMEM containing
150 lCi of [
35S] methionine/cysteine (EasyTag
TM
EXPRESS
35S Protein Labeling Mix). Cells were lysed
immediately after the pulse (time 0), or chased for 15 min–
48 h to determine the turnover of APP. Cell pellets were
lysed in 500 ll of NP-40 lysis buffer plus protease inhib-
itors (Roche), and lysates were cleared by centrifugation at
20,000 9 g for 20 min. Post-nuclear supernatants were
incubated overnight at 4C with antibody 9E10 (1/20) and
protein A-agarose beads. Immunocomplexes were washed
three times with NP-40 buffer, one time with PBS, and
eluted from the beads by boiling for 10 min in 30 llo f29
SDS sample buffer. Proteins were separated on 4–12%
NuPage (Novex
, Invitrogen) gradient gels followed by
autoradiography on an X-ray ﬁlm for a minimum of 12 h,
at -80C.
Drug treatments
To inhibit anterograde transport from ER to Golgi com-
partments, cells were treated with the fungal metabolite
brefeldin A (BFA, Sigma; B-7651), ranging from 5 lg/ml
to 30 lg/ml. Therefore, medium from cells was replaced
24 h after seeding with fresh medium containing indicated
concentrations of BFA or vehicle (DMSO) alone and
incubated from 1 to 4 h. Stock solution was prepared as
5 mg/ml in DMSO and stored at -20C. To inhibit
clathrin-mediated endocytosis, cell cultures were treated
with 10 lM chlorpromazine (Sigma; C-8138) for 30 min.
Chlorpromazine was dissolved in DMSO and stored as
stock solutions (50 mM) at -20C.
Drosophila Schneider (S2) cell aggregation assay
Semi-adherent S2 cells were cultivated at 25C with growth
medium (Schneider’s Medium (Invitrogen); 10% FCS 1%
penicillin/streptomycin (10,000 U penicillin, 10 mg strep-
tomycin/ml in 0.9% NaCl). Cells stayed adherent until
70–80% conﬂuency was reached, after which they detached
and proliferated in suspension. At this time point, cells were
passaged (1/40–1/20) after resuspending to single cell sus-
pension. S2 cells were transiently co-transfected with pMT-
Gal4 and the corresponding pUAST constructs containing
APP695, APP751, APP770 using Effectene (Qiagen), and
subjected to the cell aggregation assay as described previ-
ously [9]. Brieﬂy, expression was induced 48 h post-
transfection by the addition of CuSO4(500 lM) for 16 h. In
all experiments, comparable transfection efﬁciencies of
about 10% for all analyzed constructs were achieved. For
analysis, 4 9 10
5 cells (single cell suspension) were incu-
bated in a total volume of 1 ml fresh growth medium for 2 h
at 90 rpm on a horizontal shaker. Afterwards, cells were
transferred to poly-L-lysine coated cover slips using an
abscised 1-ml Gilson pipette tip. Cells were allowed to
attach to the cover slip for 2–3 h and subjected to immu-
nocytochemical analysis as described before [9], using anti
APP antibody (CT-20, Calbiochem) in 5% normal goat
serum in PBS (1/1,000) and anti-rabbit AlexaFluor488
(Invitrogen) as secondary antibody. For quantiﬁcation of
aggregated cells, clusters of three or more transfected cells
were scored as positive. In total, 900–1,100 transfected cells
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for each experimental setup in a blinded fashion. Statistical
signiﬁcance was tested using Students’ t test. Representa-
tive images of clustered cells were taken on a Leica laser
scanning confocal microscope with a 639 water immersion
objective.
Immunoﬂuorescence of split GFP constructs
N2a cells were grown on poly-L-lysine (Sigma) coated
coverslips (Marienfeld) in 24-well plates (Falcon) and
transiently transfected (Lipofectamine 2000, Invitrogen)
with NT HA APP695 CT 1–10 and NT HA APP695 CT 11.
Fixation of the cells followed 17 h later, for 10 min with
4% paraformaldehyde and 4% sucrose in 1x PBS at 37C.
Permeabilization followed with 0.1% NP40 in 1x PBS. The
cells were blocked with 5% (v/v) goat serum (Sigma) in
19 PBS for 1 h and the primary antibody (ER marker
Grp78, rabbit polyclonal) (StressGen), or monoclonal
mouse HA.11 antibody (Covance) and incubated overnight
at 4C. The secondary antibody, AlexaFlour-594 conju-
gated goat anti rabbit (Invitrogen), was incubated for 1 h at
room temperature. The coverslips were embedded in
Mowiol and analyzed by ﬂuorescence microscopy
(639 objective, Axio Observer Z.1, Zeiss).
Quantiﬁcation and statistical analysis
Western blots were quantiﬁed by densitometry using
ImageJ 1.44.
All graphs and statistical analyses were prepared using
GraphPad Prism 4 software (GraphPad, La Jolla, CA,
USA). Data were analyzed by one-way analysis of variance
(ANOVA) coupled to Newman–Keuls post-test for multi-
ple comparison or t test. p\0.05 was considered as
statistically signiﬁcant.
Results
Retention of APP in the ER leads to the formation
of SDS-stable homodimers
Although many aspects of APP dimerization have been
studied, the precise cellular localization of its generation
remains unclear. To identify the compartment where APP
dimerization is initiated, we ﬁrst generated chimeric pro-
teins, using APP isoform 695 with a C-terminal myc tag,
followed by either a -Lys-Lys-Ala-Ala (KKAA) or -Lys-
Lys-Phe-Phe (KKFF) dilysine signal, designated APP ER
or APP Golgi as illustrated in Fig. 1a. It has been reported
that the sequence context of dilysine signals determines the
efﬁciency of ER retention, shown for CD4-receptor
chimeras fused to either retention motif [22]. Speciﬁcally,
the KKAA chimeras were strictly localized to the ER,
unlike KKFF constructs which shuttle between ER-and cis-
Golgi compartment, due to the double phenylalanines (-FF)
acting as an ER exit determinant [20–22]. We tested the
oligomerization potential of APP trafﬁcking mutants, both
for KPI and non-KPI isoforms, in stably transfected CHO-
K1 mass cultures, expressing comparable levels of the
respective APP695 constructs. To determine whether the
addition of the KKXX motifs to the cytoplasmic tail of
APP would prevent the protein from being transported to
the cell surface, we compared retention mutants to APP695
wt, by ﬁrst employing surface biotinylation experiments
(Fig. 1b). Protein expression was analyzed using SDS-
PAGE and subsequent Western blotting of total cell lysates
(Fig. 1b, left panel). In the biotinylation, no APP full
length was detected for any of the retention mutants,
indicating a strong intracellular retention mediated by
double-lysine motifs (Fig. 1b right panel), whereas
APP695 wt appeared in its fully glycosylated form at the
plasma membrane (Fig. 1b right panel, APPﬂ mature). In
the lysate controls, APP695 migrated as a set of two bands
(*110–130 kDa) representing immature, mostly ER gly-
cosylated APP, and the mature protein that has undergone
complex O-glycosylation in the late-Golgi compartment.
Surprisingly, for APP ER, two distinct migrating bands
appeared in the lysate controls (Fig. 1b, left panel), of
which the faster migrating band (*110 kDa) represents
immature APP (before cis-Golgi-speciﬁc carbohydrate
modiﬁcations) consistent with permanent ER retention.
Additionally, we found an explicit slower migrating band
for APP ER, co-migrating at the apparent molecular weight
of a putative APP dimer (*220 kDa). This was particu-
larly interesting, because in our experimental conditions we
treated all lysate samples with loading buffer, containing
SDS and b-mercaptoethanol (BME) prior to electrophore-
sis, but most importantly, the samples were not heat
denatured at the same time (Fig. 1b, left panel, ?BME/-
95C). Since the upper band did not disappear upon SDS
treatment, we assume that stronger forces, other than
hydrophobic associations, must be involved in APP dimer
formation, such as intermolecular disulﬁde bonds. This
notion was strengthened by the fact that retention of
APP695 in the ER seemed to be sufﬁcient to visualize
SDS-stable homodimers, most likely generated via disul-
ﬁde bonds between cysteine residues located in the E1
ectodomain. However, APP Golgi (containing the ‘‘leaky’’
KKFF motif) did not reveal an upper high-molecular-
weight species around *220 kDa, although it migrated
exclusive as immature APP (Fig. 1b, Input) and was absent
from the cell surface (Fig. 1b, PD NeutrAvidin, right
panel), equivalent to APP ER. We hypothesize that APP
bearing the ER exit determinant (-FF) shuttles permanently
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in less APP molecules at steady state in the ER, making it
difﬁcult to capture dimerization with our experimental
conditions. However, this does not exclude that disulﬁde-
associated APP dimers also exist in other compartments,
but under normal cellular conditions this likely represents a
sub-population of APP dimers, among others, held together
by hydrophobic interactions, normally dissolved by the
presence of SDS. Since it was recently proposed that APP
can form dimers at the cell surface [9, 11, 19], we intended
to include the plasma membrane as a putative source of
dimerization. To do so, we transiently co-expressed a
dominant negative (D/N) mutant of adaptor protein 180
(AP180) (Fig. 1b, right panel), inhibiting clathrin-mediated
endocytosis [25, 26], thereby retaining APP at the plasma
membrane and increasing its surface exposure. Indeed,
mature APP wt was strongly increased at the cell surface
and in the lysates controls upon co-expression of AP180
D/N (Fig. 1b left and right panel, lane four). Nevertheless,
we failed to monitor any SDS-stable dimers when retaining
APP at the surface, possibly because under normal cellular
conditions the amount of covalent APP dimers reaching the
surface is below detection limit on Western blots. Never-
theless, we demonstrate that stable APP dimer formation
Fig. 1 ER-retention of APP by addition of the di-lysine motif KKAA
induces SDS stable homo-dimers in an oxidizing cellular surrounding.
a Schematic illustration of the APP domain structure and the used
dilysine retention constructs. APP isoform 695 (APP695) was fused to
a C-terminal myc-tag, followed by either a KKAA ER retention motif,
or a ‘‘leaky’’ KKFF motif allowing trafﬁcking to the cis-Golgi
compartment. The E1 domain, acidic domain, E2 domain, transmem-
brane domain (TM), and the intracellular domain are indicated.
b CHO-K1 cells stably over expressing the respective APP695 wt or
APP695 retention constructs were subjected to cell surface biotinyl-
ation. To inhibit endocytosis from the cell surface, AP180 D/N (lane
four) was transiently co-expressed. At 24-h post-transfection, cell
surface proteins were labeled with sulfo NHS-SS-biotin at 4C, prior
to lysis. Biotinylated samples were precipitated with NeutrAvidin
agarose beads and analyzed by SDS-PAGE and Western blot (PD:
NeutrAvidin; right panel). As input controls, 20 lg ofcell lysates were
used (input; left panel). APP full length, CTFs and AP180 D/N were
probed with 9E10 antibody. Monoclonal a-Tubulin antibody served as
a loading control to verify the absence of endomembrane contaminants
in the biotinylation. For the input control, all samples were treated with
SDS sample loading buffer, containing b-mercaptoethanol (BME)
without heat denaturing prior to SDS gel electrophoresis. To elute
surface proteins from NeutrAvidin beads, samples were denatured for
5 min at 95C with BME and separated on 4–12% SDS gels.
Molecular weight standards (kDa) are indicated on the left. c Cell
lysates (20 lg each lane) of CHO-K1 cells stably overexpressing APP
ER (KKAA), were incubated with SDS sample loading buffer
(? BME) and heat denatured for 10 min at the indicated temperatures
(4–85C). APP monomers and SDS stable dimers were detected, using
the monoclonal anti myc antibody (9E10), shown on one represen-
tative Western blot. d APP dimers and monomers were quantiﬁed by
densitometric analysis of Western blots, as the one shown in c. In each
case, intensities at 4C were set as 100%. Diagram shows relative
intensity (%) of APP monomers and dimers, plotted against different
temperatures. Data are (n C 3) ± SEM, one-way ANOVA
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123starts early in the secretory pathway, in the ER. Interest-
ingly, when we reversed the experimental conditions and
heat denatured the samples, without adding BME, we
detected even higher-molecular-weight species, likely
representing oligomerized APP (data not shown). These
data indicate for the ﬁrst time that the actual APP dimer-
ization most probably occurs in the ER and that
intermolecular disulﬁde bond(s) might be involved in APP
dimerization. Furthermore, this reveals that APP probably
exists in a monomer–dimer equilibrium, and that covalent
disulﬁde bonds represent one mechanism of how APP
dimerization might be achieved. Additionally, we
employed two additional APP antibodies against the C-or
N-terminus and conﬁrmed the upper band as speciﬁc for
APP (data not shown). To further assess the involvement of
disulﬁde bonds in APP dimer formation, we applied
stronger denaturing conditions to determine up to which
temperatures the dimers remain stable in the presence of
the reducing agent BME (Fig. 1c). We established a tem-
perature curve, mixing equal amounts of lysates from APP
ER overexpressing CHO-K1 cells with SDS sample buffer
(5% BME ﬁnal conc. in samples), prior to heat samples for
10 min at the indicated temperatures (4–85C, Fig. 1c).
Immunoblotting with 9E10 antibody revealed that dimers
persisted up to 50C, whereas higher temperatures led to a
progressive decline, ﬁnally resulting in the total disap-
pearance of the upper band at temperatures over 60C.
Quantiﬁcation of immunoblots clearly showed a corre-
sponding increase of *50% in monomers vice versa
(Fig. 1d). These results indicated that under standard
detergent lysis conditions, APP forms disulﬁde-linked
dimers which can only be fully disrupted by extended
heating of protein samples in the presence of BME.
ER retention does not affect APP biosynthesis
but increases its half-life
We next investigated whether it is possible to visualize the
dimerization of unmodiﬁed wild-type APP695 (APP695
wt) without adding a C-terminal retention signal. To test
this, we applied brefeldin A (BFA), a macrocyclic lactone
antibiotic, inhibiting protein secretion at an early step in the
secretory pathway [27–30]. It has been shown that BFA
leads to rapid redistribution of the Golgi apparatus into the
ER, inhibiting the anterograde movement of membrane
trafﬁc beyond the mixed ER/Golgi system, thereby
retaining secretory and membrane proteins in the ER [27–
30]. Cell cultures, overexpressing APP ER or APP wt were
treated with 5 lg/ml BFA for different time periods
(0–8 h) at 37C, to block ER export. Subsequently, lysates
were separated on a non-reducing SDS-PAGE, followed by
immunoblotting with the APP speciﬁc polyclonal antibody
CT15. Indeed, we found that addition of BFA to cell
cultures caused the formation of an SDS-resistant high-
molecular-weight band for APP wt, which co-migrated
with the upper band of APP ER. A longer exposure of the
same blot showed a beginning dimer formation already
after 1 h treatment (Fig. 2a, longer exposure and Fig. 2b),
with further increase after 8 h. Moreover, the difference
between mature and immature APP becomes indistinct, due
to the accumulation of particular immature APP in the ER.
Interestingly, we also found a stabilizing BFA effect on
pre-existing dimers, generated by APP ER (Fig. 2a, c),
suggesting that even APP dimerization can be increased
when ER exit was further inhibited by the application of
BFA. However, the strong increase in monomers for APP
ER was due to the employed antibody (CT15), also
detecting the fraction of endogenous APP from CHO cells.
In contrast, treatment of cell cultures, overexpressing APP
ER, with increasing concentrations of BFA (10–30 lg/ml)
for 1 h, led to an inverted monomer–dimer equilibrium
(Fig. 2d–f) with a 50% decline in monomers, accompanied
by a twofold increase in dimers (Fig. 2e, f). Strikingly, this
effect was now visible with 9E10 antibody, exclusively
detecting overexpressed APP, since endogenous APP from
CHO cells obscured this previously (compare Fig. 2a).
Nevertheless, this effect was highly reproducible and not
dose-dependent. Taken together, these results implicated
that not all APP molecules retained in the ER, have nec-
essarily transformed into a dimeric state so far. Thus,
extended exposure of APP to an oxidative surrounding had
a considerable inﬂuence on the monomer–dimer balance,
favoring dimerization. To investigate a potential inﬂuence
of ER-retention on the half-life and biosynthesis of APP,
we performed a pulse-chase analysis (Fig. 2g). Following a
15-min pulse with 150 lCi of [
35S]-methionine/cysteine,
we found no difference in the generation of immature APP
between APP695 wt, versus APP695 ER (0 min). At
time zero, APP consists predominantly of immature
N-glycosylated species in both cell lines. However, fully
mature APP appeared after 15 min exclusively in APP695
wt cells, and becomes stabilized after 30 min, thus
reﬂecting trafﬁc through the Golgi compartment. After a
1-h chase period, the APP wt level was dramatically
reduced (Fig. 2h, half-life APP wt 45 min) and hardly
detectable after 4 h. In contrast, cells overexpressing the
AP ER retention mutant did not generate any O-glycosyl-
ated, mature APP during the chase period. However,
turnover of APP ER is signiﬁcantly prolonged, and *50%
of total APP can still be detected even after 5.5 h (Fig. 2h).
Thus, the half-life of APP ER is more than sevenfold
longer than in APP695 wt cells. Note that different chase
time points for the APP ER mutant were chosen after an
initial pulse-chase experiment already suggesting a pro-
longed half-life (data not shown). We also conﬁrmed that
retention in the ER severely limits APP metabolism,
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123Fig. 2 Homodimerization of APP wt can be induced by inhibiting
protein trafﬁc out of the ER with brefeldin A. a CHO-K1 cells stably
overexpressing either APP695 wt or APP695 fused to the ER retention
motif KKAA (APP695 ER) were treated with 5 lg/ml brefeldin A
(BFA) for the indicated time points (0–8 h). Aliquots of cell lysates
were mixed with SDS sample buffer, containing BME without heat
denaturing and separated on a 4–12% SDS-PAGE. APP was detected
with CT15 antibody, shown on one representative Western blot. The
bottompanelshowsalongerexposuretime,indicatingdimerformation
of APP695 wt when export of the ER is blocked by BFA. b Diagram
showing the ratio of APP wt dimer formation during BFA treatment,
plotted against time, with ± SEM of three independent experiments,
statistical signiﬁcance: ***p\0.001, one-way ANOVA. c Diagram
depictingincreasing stabilization ofAPPERpreexisting dimersduring
BFA treatment, plotted against time. Data represent ± SEM (n C 3),
statistical signiﬁcance: ***p\0.001, one-way ANOVA. d Cell cul-
tures of CHO-K1 overexpressing APP ER were treated for 1 h with
increasing concentrations (10–30 lg) of BFA, or with vehicle (100%
ethanol)alone.Samplesweretreatedasundera.APPwasdetectedwith
monoclonal 9E10 antibody, shown as one representative Western blot.
e Diagram showing relative increase of APP ER dimers with higher
BFA concentrations, quantiﬁed as percentage over vehicle control.
Data represent ± SEM as indicated (n C 3). Statistical signiﬁcance:
***p\0.001, t test. f Diagram showing simultaneous reduction of
APP monomers with increasing BFA concentrations, depicted as
percentage of vehicle control. Data represent ± SEM as indicated
(n C 3). Statistical signiﬁcance: ***p\0.001, t test. g ER retention
inhibits APP degradation and increases its half-life. CHO-K1 cell
cultures stably overexpressing either APP695 wt or APP695 ER,
respectively, were pulse-labeled for 15 min with 150 lCi of [
35S]
methionine/cysteine. Cells were harvested immediately after the pulse
(0 min), or chased for the indicated time points with non-radioactive
medium. APP was immunoprecipitated with monoclonal 9E10 anti-
body and subjected to SDS-PAGE followed by autoradiography on an
X-ray ﬁlm for a minimum of 16 h at -80C. Note that different time
points for APP695 ER were chosen due to its extended half-life. APP
mature (APP m)and immature form (APP imm) are indicated. Alltime
pointswere run induplicates. For APPER,samples were run alongside
an APP wt control sample to conﬁrm the difference between immature
and mature APP. h Half-life graph. Data are mean ± SEM of four
independent experiments. *** Statistically signiﬁcant difference
(p\0.001; t test) between APP wt and APP ER is indicated
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culture medium (data not shown), since access to secretases
is prevented [31, 32].
APP wild-type homodimers are initially formed
in the ER but occur also at the cell surface
We have shown that retention of APP695 in the ER, either
by a C-terminal ER retention motif, or blocking its export
with BFA, led to the formation of SDS stable homodimers
(Fig. 1). To verify that APP dimerization occurs early in
the secretory pathway, we attempt to use a different
approach. We employed a GFP tagging system for the
intracellular detection of APP695, which is based on the
auto-assembly capacity of two non-ﬂuorescent portions of
GFP, termed GFP 1–10 and GFP 11. When brought toge-
ther by the association of two interacting partner proteins,
individually fused to the fragments, they restore a fully
ﬂuorescent GFP, termed bimolecular ﬂuorescence com-
plementation (BiFC) [24]. This enables us to visualize
APP–APP interactions and their subcellular localization
under physiological conditions [24]. Therefore we fused
the two complementary GFP fragments separately to the
C-termini of HA-APP695 [9] and co-expressed both con-
structs in neuroblastoma N2a cells (Fig. 3a). The green
ﬂuorescence in cells co-expressing the BiFC constructs
clearly indicates an interaction of APP molecules under
physiological conditions. We observed a punctate vesicular
staining, possibly resembling Golgi or endosomal struc-
tures and also an ER staining, as indicated by co-staining
with the ER marker protein Grp78 (overlay). These data
corroborate, together with our data based on the ER
retention signal, that APP dimerization occurs in the
endoplasmic reticulum (ER) before its trafﬁcking through
the Golgi to the cell surface. Due to its rapid travel along
the secretory pathway, we observed the same outcome on
SDS-PAGE, only when we mediated APP retention in the
ER (Figs. 1, 2). By contrast, no speciﬁc GFP ﬂuorescence
was detected when single halves of GFP fused to APP
(APP-GFP 1–10 and APP-GFP 11) were individually
expressed in N2a cells (Fig. 3b). To rule out that the non-
detectable GFP signals in the negative controls might result
from no expression of transfected plasmids, we performed
immunostainings of HA-APP (Fig. 3b, right part), clearly
revealing the presence of the APP fusion proteins. More-
over, this conﬁrmed that the split GFP does not perturb the
true APP localization in the cell, since expression patterns
of negative controls were comparable to those of APP
BiFC in the positive controls. Additionally, the expression
levels of the APP-GFP fusion proteins in the positive and
negative controls were also conﬁrmed by Western blotting
(Fig. 3c).These results suggest that APP dimers are initially
formed in the ER. However, it cannot be ruled out that
dimerization might occur at later stages of the transport.
Having established that APP695 wt can form homodimers
at an early stage in the secretory pathway, this does not tell
us whether these dimers are caused by disulﬁde bonds or
other interactions. We therefore wanted to show that
disulﬁde bridged APP homodimers are in fact generated in
the ER, but do also occur naturally in the cell. The APP ER
retention construct has proven as a reliable tool to visualize
stable dimer formation in the ER, nevertheless since it does
not trafﬁc beyond ER, we cannot use this construct to show
the existence of disulﬁde linked APP dimers in other cel-
lular compartments, e.g., at the plasma membrane. We
employed a different approach to demonstrate that dimers
generated in the ER can indeed reach the cell surface. We
ﬁrst slowed down anterograde ER-to-Golgi transport [27–
30] by pre-treating cells overexpressing APP 695 wt with
Fig. 3 APP wt homodimers are formed in the ER but also occur at
the cell surface. a N2a cells were transiently co-transfected with NT
HA APP695 CT Split GFP 1–10 and NT HA APP695 CT Split GFP
11. The cells were ﬁxed with paraformaldehyde and immunostained
with ER marker Grp78, followed by incubation with AlexaFlour-594
conjugated secondary antibody. The green ﬂuorescence represents the
APP dimer, induced by bimolecular ﬂuorescence complementation
(BiFC). Co-staining with Grp78 revealed colocalization of the APP
dimer (inset) with the ER. b Single transfections of N2a cells with
either NT HA APP695 CT Split GFP 1–10 or NT HA APP695 CT
Split GFP 11. APP expression was veriﬁed with HA antibody,
conﬁrming a non-perturbed distribution (right panel, red). The green
channel does not show any speciﬁc ﬂuorescence. Scale bar is 10 lm.
c N2a cells were transiently transfected with NT HA APP695 CT
Split GFP 1–10, NT HA APP695 CT Split GFP 11 or GFP only. Cell
lysates were analyzed via Western blotting for APP full length (top
part), APP CTFs (middle part) and GFP, or GFP-containing CTFs
(bottom part). Note that GFP antibody does not recognize GFP 11
alone. d CHO-K1 cells stably overexpressing APP 695 wt were
pretreated for 1 h at 37C in the presence of 10 lg/ml brefeldin A
(BFA), or DMSO (vehicle) for 1 h to block protein secretion from the
ER. Subsequently, cells were either directly lysed (BFA), or medium
containing BFA was removed, and cells were incubated for additional
30 min at 37C with 10 lM chlorpromazine (BFA/CPZ), to allow
transport to the cell surface, but inhibit further endocytosis. Lysates
were analyzed either under non-reducing (?b mercaptoethanol;
-95C), or reducing conditions (?b-mercaptoethanol; ?95C). Note
that cells pretreated with BFA, followed by chlorpromazine exposure
(BFA/CPZ), display two upper SDS-resistant bands migrating with a
slight size shift, indicating different glycosylation patterns (dimer
i/m). Note that strong denaturing conditions (?95C) result in the
disappearance of the upper migrating bands, suggesting disulﬁde
bond formation. The separating line indicates different exposure times
to visualize dimer formation in treated cells, whereas APP ER
overexpressing cells served as size reference for dimers. e Cells were
treated as described under d, and subjected to cell surface biotinyl-
ation to conﬁrm drug treatments. APP ER is completely absent from
the surface, whereas only minor quantities of mature APP reach the
surface upon BFA treatment. Removal of BFA, and subsequent
incubation with chlorpromazine (BFA/CPZ), strongly increases
surface exposed mature APP, compared to vehicle control. Note that
no dimers are recovered in biotinylation, because NeutrAvidin beads
were boiled in BME containing sample buffer, to release biotin
conjugated proteins
c
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12310 lg/ml BFA for 1 h to allow efﬁcient dimer formation in
the ER (Fig. 3d). Next, cells were either directly lysed, or
BFA was washed out and cultures were incubated for an
additional 30 min at 37C with medium containing chlor-
promazine (CPZ, 10 lM). Chlorpromazine prevents
assembly of the adaptor protein-2 (AP-2) on clathrin-
coated pits and thus causes a loss of endocytosis [33].
Subsequently, cells were lysed or optionally subjected to a
surface biotinylation (Fig. 3e). As expected, upon BFA
treatment APP disappeared from the cell surface, veriﬁed
by biotinylation (Fig. 3e). Furthermore, we were able to
trigger APP695 wt dimer formation, as seen previously
(compare to Fig. 2a). In contrast, removal of BFA rapidly
restored protein secretion from the ER to the Golgi and the
cell surface [29, 30], and APP reappeared at the plasma
membrane, established by CTF generation and fully gly-
cosylated species, both in lysates and biotinylation
experiments (Fig. 3d, e). Strikingly, chlorpromazine (CPZ)
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123treatment led to a marked re-establishment of mature APP
at the surface, compared to vehicle control (Fig. 3e), and
BFA/CPZ treatment caused the formation of SDS-resistant
high-molecular-weight species, migrating as a doublet
(Fig. 3d). We assume that the slight size shift of the upper
bands represents different glycosylated APP dimers, indi-
cating transport along the secretory route. However, this
higher ‘‘mature’’ dimer was absent in APP ER-or BFA-
treated APP695 cells, suggesting that dimers were initially
generated in the ER, but can be effectively transported
through the secretory pathway, reaching the cell surface.
This was particularly visible upon blocking endocytosis,
thus preventing newly generated dimers from being
instantly re-internalized. Note that heating the samples
(?95C) with BME resulted in the disappearance of the
upper band(s), supporting our proposed model that APP
dimers can associate via covalent intermolecular disulﬁde
bonds.
APP homodimerization is dependent
on the extracellular cysteine-rich E1 domain
of the protein
Findings so far, by us and others, strongly argue for a
mechanism that drives APP dimerization by its N-terminal
cysteine-rich E1-domain [9, 11]. To further dissect the
mechanisms by which APP homodimerization is accom-
plished and to exclude a potential interaction via its
cytosolic part, we co-expressed C-terminal adaptor proteins
in order to compete for binding, possibly perturbing or
diminishing homodimerization (Fig. 4a). The intracellular
domain of APP contains one YENPTY motif, which has
been shown to interact with several adaptor proteins
including FE65, X11, JIP, Shc, Tip60, and Dab1 [34, 35].
Speciﬁcally, we overexpressed increasing amounts of
either Fe65 or X11a in CHO cells stably transfected with
APP ER (Fig. 4a), thus providing a putative sterical hin-
drance for APP dimers. We observed a slight increase in
APP monomers as well as dimers with co-expression of
Fe65 and a more severe effect for X11a. This is consistent
with previous ﬁndings that both adapter proteins stabilize
either APP intracellular fragments or increase the half-life
of full length APP [36, 37]. Additionally, we conﬁrmed
a direct binding of Fe65 to APP wt and APP ER by
co-immunoprecipitation experiments and successfully
co-puriﬁed equal amounts of ﬂag-tagged Fe65 (data not
shown). These results showed that Fe65 can interact efﬁ-
ciently with the APP ER mutant via its cytosolic exposed
C-terminal part, while the APP N-terminus remains
directed into the ER lumen where disulﬁde-bridged
dimerization can occur. We next set out to ascertain that
the *220-kDa band indeed represented an APP homodi-
mer and not any heterodimer of APP with another protein
of the same putative molecular mass. Therefore, we gen-
erated an additional APP695 construct with a C-terminal
HA tag and co-expressed APP695 HA wt or its ER retained
counterpart (APP695 HA ER) in CHO cells, stably over-
expressing APP695 myc ER (Fig. 4b). The overexpressed
APP-myc and APP-HA fusion proteins were probed with
mouse anti-myc or rat anti-HA primary antibodies vice
versa on different immunoblots. In fact, we conﬁrmed that
the high-molecular-weight band represented APP homo-
dimers, since Western blots with either myc-or HA-
antibody, independently revealed a band at *220 kDa in
cells co-expressing HA-tagged and myc-tagged APP spe-
cies. Individually, the APP HA and APP myc proteins
migrate as distinct and separable bands under either
reducing or non-reducing conditions (Fig. 4b). However, in
the presence of reducing and denaturing conditions
(?95C), dimers were converted to monomers, which
increased simultaneously (Fig. 4b, upper right blot).
Interestingly, co-transfection of APP HA wt into cells
already expressing APP myc ER revealed a slightly weaker
band around *220 kDa with HA antibody (Fig. 4b, bot-
tom blot, third lane), in addition to the doublet representing
both maturation states of APP. This band most likely rep-
resents a dimer composed of APP myc ER and APP HA wt,
suggesting that APP695 ER could retain a portion of wt
APP within the ER, due to homodimer formation. The most
feasible interpretation of our approach is that these high-
molecular-weight bands represent APP myc/APP HA
‘‘heterodimers’’, indicating that APP forms homodimers
within the same cellular compartment (cis-dimers). Finally,
these ﬁndings also minimized the possibility that APP
happens to ‘‘heterodimerize’’ with any other unrelated
protein of the same molecular weight. Moreover, this is in
agreement with our BiFC approach (Fig. 3), already dem-
onstrating a speciﬁc interaction of two APP695 molecules,
by restoring a functional ﬂuorescent GFP. It has been
shown by co-immunoprecipitation experiments and FRET
analysis that deletion of the E1 domain impedes APP
homodimerization [9, 11] as well as heterointeraction with
APLPs [9, 11]. Accordingly, we hypothesized that APP
lacking the cysteine-bearing E1 domain is no longer
capable of dimer formation in the ER. This region of APP
encompasses the growth factor-like domain (GFLD) and a
copper-binding domain (CuBD) [38, 39], which contain
together 12 cysteine residues, possibly promoting stable
covalently linked dimers or higher multimers. We gener-
ated CHO-K1 cell lines, overexpressing APP695 deletion
constructs, lacking the N-terminal growth factor-like and
copper-binding domains (DE1), thereby omitting all of the
cysteines and compared them with cells expressing the
corresponding full-length constructs (Fig. 4b). Indeed, the
KKAA motif particularly retained APPDE1 ER in the cell,
conﬁrmed by surface biotinylation (Fig. 4c, right panel)
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123Fig. 4 APP homodimerization is dependent on cysteine residues in
the E1 domain. a CHO-K1 cells stably overexpressing APP695
KKAA (APP ER), were transiently co-transfected with increasing
concentrations (1-, 2-, 3 lg) of plasmid DNA encoding C-terminal
adaptor proteins Fe65, X11a or empty vector. The upper Western blot
shows myc tagged APP ER full length (immature form, lacking Golgi
glycosylation pattern) and SDS stable dimers, at molecular weight of
*220 kDa. The lower blots depict transfection controls, using either
ﬂag antibody for Fe65, or 9E10 for X11a. b CHO-K1 cells stably
overexpressing myc-tagged APP695 ER, were transiently co-trans-
fected with HA-tagged APP constructs, APP695 HA ER or APP 695
HA wt. Western blotting with myc (mouse) or HA (rat) antibody
reveals dimers (*220 kDa myc-/HA-APP) under non-reducing
conditions, separated on 4–12% acrylamide gradient gels. In the
presence of BME and 95C, APP dimers are converted to monomers,
migrating at *110 kDa. Note that dimers can be detected with both
antibodies and myc dimers are increased when APP HA ER is
co-expressed (top blot, second lane). Additionally, a weak dimer band
occurs when APP HA wt is co-expressed in APP myc ER cells
(bottom blot, third lane). This suggests that APP myc ER can retain a
portion of APP HA wt in the ER and that dimers are indeed
homodimers consisting of APP myc and APP HA. c CHO-K1 cells
stably overexpressing APP695 wt, APP695 ER, or the respective
constructs, lacking most of the extracellular part (APPDE1 and
APPDE1ER, compare Fig. 3d), were subjected to surface biotinyla-
tion. Biotinylated samples were precipitated with NeutrAvidin
agarose beads, followed by SDS-PAGE and Western blot (PD:
NeutrAvidin; right panel) and corresponding cell lysates were used as
input controls (input; left panel). APP full length, APPDE1 and CTFs
(comigrating *12 kDa MW) were detected with 9E10 antibody, note
that APP lacking the E1 domain migrates faster at *75 kDa.
d Cysteine residues at positions 98 and 105 within the APP
extracellular (E1) domain are critical for disulﬁde bridged dimers,
generated in the ER. Cysteines at positions 98 and 105 were
substituted by hydrophilic serine residues. Lysates of CHO-K1 cells
stably overexpressing APP wt or APP ER, or transiently transfected
with APP ER 98-105ser, were analyzed on 4–12% SDS gels and
immunoblotted with 9E10 antibody for APP. Note, despite an
effective retention, APP homodimerization was impaired in forming
homodimers when cysteine residues 98 and 105 are converted to
serines, precluding the formation of disulﬁde bonds between the
absent thiol groups. e Schematic illustration of APP695 ER and the
corresponding APPDE1 ER construct. For the APP deletion construct,
the signal peptide sequence of APP was introduced in frame with the
remaining domains, starting with the acidic region. Deletion of the
entire, cysteine-rich E1 domain abolished APP dimerization via
disulﬁde bond formation, as shown under b. Molecular mass standard
is indicated on the left side of the blots
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(Fig 4 c, left panel). Strikingly, the generated deletion
constructs were incapable of forming stable high-molecu-
lar-weight species, regardless of ER retention or not
(Fig. 4c), indicating that the E1 domain is essential for
generating SDS-resistant APP homodimers (compare
illustration in Fig. 4e). Note that less mature APPDE1 was
detected at the surface compared to APP695 wt, likely due
to less free primary amino groups for biotin attachment,
present in the N-terminal truncated APP construct. It has
been reported that APP contains a region within the E1
domain, encompassing residues 99–110, with an active
heparin binding capacity [38] that might form a loop, sta-
bilized by a disulﬁde bond between Cys-98 and Cys-105.
Based on ﬁndings that a synthetic peptide corresponding to
the loop residues was able to interfere with APP dimer-
ization [10], we generated an ER-retained APP loop double
mutant exchanging Cys-98 and Cys-105 for serine residues
(APP ER 98-105ser). We compared cell extracts from
CHO-K1 cells transiently transfected with the serine
mutant to lysates of our stably expressing APP 695 wt and
APP695 ER cells (Fig. 4d). Western-blot analysis clearly
demonstrated that the APP ER 98-105ser mutant failed to
form homodimers in an oxidizing environment when
sulfhydryl groups were exchanged by hydroxyl groups,
compared to APP ER, which contains the respective cys-
teine residues. Thus, we conclude that these cysteines
located within the APP heparin-binding site are sufﬁcient
to mediate APP homointeraction, and that binding of two
N-terminal domains of APP was entirely dependent on the
oxidation of the thiol groups. However, at this point we
cannot exclude the possibility that cysteine mutants other
than those analyzed would have had similar effects on APP
dimer formation. Nevertheless, this indicates for the ﬁrst
time that cysteines, located within the E1 domain, might
also contribute to cis-dimerization between two adjacent
APP molecules, via intermolecular disulﬁde bonds, as well
as stabilizing the APP structure via intramolecular S–S
bonds (see illustration in Fig. 4e). We conﬁrmed the
necessity of the E1 domain for APP N-terminal interac-
tions, by generating APP truncated at the b-secretase site
[40], C99 wt or C99 ER (data not shown). Thereby the
entire extracellular part, including the central E2 domain,
was absent and Western-blot analysis revealed no SDS-
stable dimers for C99 wt or the C99 ER.
Heterointeraction between APP and its homologue
APLP1 is initiated and increased in the ER, depending
on the APP E1 domain
Various experimental approaches have demonstrated that
APP is capable of forming heterodimers with its homo-
logues, APLP1 and APLP2 [9, 11], both intracellular in
cis- and intercellular in trans-manner [9]. Since we could
deﬁne the ER as the cellular compartment providing ideal
conditions for triggering APP695 homointeractions via
disulﬁde-bridge formation, we investigated whether this
mechanism would also contribute to heterodimerization
between APP and APLP1. As a ﬁrst biochemical approach,
we performed a cell surface biotinylation in our CHO-K1
cells stably overexpressing either APP695 wt or APP ER,
transiently co-transfected the human APLP1 cDNA
(Fig. 5a). Co-expression of APLP1 resulted in a signiﬁcant
reduction of APP695 ER homodimers (Fig. 5a, upper
panel, lane 4) representing a decrease of more than 60%
(Fig. 5b), accompanied by the simultaneous formation of
APP/APLP1 heterocomplexes in the ER (Fig. 5a lower
panel, lane 4 and Fig. 5c). At the same time, we monitored
an increase of *50% in APP monomers (Fig. 5b), indi-
cating that a portion of APP homodimers was converted
back to monomers, whereas the rest appeared as hetero-
dimers with APLP1. Despite equal expression of APLP1 in
both cell lines (Fig. 5a, bottom panel), we found less
mature APLP1 at the surface when co-expressed with
APP695 ER (Fig. 5a, bottom panel, lane 2 and 4), corre-
sponding to a 50% reduction when compared to APP695 wt
(Fig. 5d, bottom panel, lane 2 and 4). This indicates that
the interaction of APP and APLP1 occurs already in the
ER, and that APP can potentially retain a portion of APLP1
in the ER as a consequence of forming stable heterocom-
plexes. Interestingly, we found less C-terminal fragments
for APLP1 when co-expressed with APP ER, suggesting
impaired generation due to ER retention. Note that only
fully mature proteins appear at the cell surface whereas
secretase derived metabolites (CTFs) are only visible in the
lysate controls of APP695 wt and APLP1. To provide
further evidence for the interaction between APP and its
homologue APLP1, we performed co-immunoprecipitation
studies in our stable CHO-K1 cells upon co-expression of
human APLP1 (Fig. 6). Lysate controls and co-puriﬁed
proteins (IP APLP1 or APP) clearly indicate a strong
interaction between both proteins in the ER. However, APP
homodimerization in the ER is reduced upon APLP1
co-expression (Fig. 6b lysate WB 9E10, lane 4), compared
to APP695 ER alone (compare Fig. 6b). At the same time,
we observed again the formation of a distinct higher-
molecular-weight band for APLP1 in cell lysates, only
when co-expressed with APP695 ER, as seen previously
(Fig. 5a, bottom blot). In line with the biotinylation
approach (Fig. 5a), this band most likely represents APP/
APLP1 heterocomplexes, since it co-migrates with the size
of APP homodimers (*220 kDa) and both homologues
have about the same molecular mass. Furthermore, speciﬁc
interaction between both proteins was conﬁrmed in APP-
and APLP1-directed co-immunoprecipitation experiments
(Fig. 6, lower panels). Most interestingly, the amount of
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APP was retained in the ER. Taken together, our ﬁndings
clearly demonstrate a heterocomplex formation between
APP and APLP1 as early as in the ER, most likely via
disulﬁde-bond formation between the respective cysteine-
bearing E1 domains of both proteins.
Intracellular cis-dimerization of APP770 in the ER is
diminished by the KPI domain, but can be induced
by a constitutive cysteine bond at the transmembrane
domain
All studies investigating APP dimerization so far have used
exclusively the neuronal APP isoform 695 or APLP1 [9,
11, 13, 17]. However, most tissues and glial cells express
APP with an additional KPI domain, a 57-amino-acid
insert, showing homology to the Kunitz family of serine
protease inhibitors [41]. Therefore, we wanted to explore
whether APP harboring an additional KPI domain in its
extracellular part would display the same dimerization
pattern as seen for APP695, since it possesses six further
cysteine residues, additional to 12 located within the E1
domain. We generated CHO-K1 cells with stable overex-
pression of APP770 wt or the respective ER retention
mutant (APP770 ER), or we transiently overexpressed APP
751 in CHO-K1 cells to include all different isoforms
(Fig. 7a). Surprisingly, when we compared lysates of cells
expressing APP695 ER to cells transfected with the longer
isoforms APP770 ER and APP751 ER, we did not observe
an explicit slower migrating band representing SDS-stable
APP-homodimers (Fig. 7a). However, APP770 ER and
APP751 ER also appear as single bands representing
Fig. 5 Heterodimerization between APP and APLP1 can be initiated
and increased in the ER. a CHO-K1 cells stably overexpressing either
APP695 wt or APP695 ER were transiently co-transfected with
human APLP1 cDNA, or empty vector alone (–). The 24 h post-
transfection cells were labeled with sulfo NHS-SS-biotin and
biotinylated samples were precipitated with NeutrAvidin agarose
beads (PD: NeutrAvidin; right panel). APP full length and CTFs were
detected with 9E10 antibody. APLP1 full-length and C-terminal
fragments were stained with the polyclonal APLP1 antibody 171615
and a-Tubulin served as a loading control. For detection of surface
proteins, NeutrAvidin beads were treated with reducing loading
buffer and heated at 95C, whereas input controls were not heat
denatured. All samples were separated on 4–12% SDS gradient gels.
Note that heterointeraction of APLP1 and APP695 ER diminishes
APP homodimers in the ER and lowers surface levels of mature
APLP1. Shown is one representative Western blot. b Diagram
showing relative changes in APP dimers and monomers when
co-transfected with pcDNA3 or APLP1. Data represent ± SEM as
indicated (n C 3). Statistical signiﬁcance: ***p\0.001, **p\0.01,
t test. c Graph showing formation of APP/APLP1 heterodimers when
co-expressed with APP ER. Data are expressed as percentage increase
over APP wt and represent mean ± SEM as indicated (n C 3),
statistical signiﬁcance: ***p\0.001, t test. d Diagram showing
signiﬁcant reduction in APLP1 surface levels when co-expressed with
APP ER, compared to when co-expressed with APP wt, as ± SEM
(n C 3) and statistical signiﬁcance **p\0.01, t test
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absent. Moreover, the absence of CTFs conﬁrmed ER
retention of all APP isoforms (Fig. 7a, bottom panel)
compared to wild-type constructs. Additionally, we gen-
erated APP of all three isoforms with a C-terminal HA tag
and transiently overexpressed them in a different cell line
(HEK 293T) to assure the previous result. Indeed, we found
no dimerization for the KPI domain containing isoforms
upon ER retention (data not shown). These ﬁndings raised
the possibility that the KPI domain might hinder cis-
directed lateral homodimerization of APP within the cell,
possibly due to different intramolecular folding, providing
a sterical obstruction. We next wanted to investigate
whether it is possible to force lateral cis-dimerization of
APP770 in our cellular system. Therefore, we introduced a
single cysteine substitution at the APP juxtamembrane
region, previously described by Scheuermann and col-
leagues, to obtain covalently stabilized dimers through an
intermolecular disulﬁde bond [8]. Since substitution of the
basic lysine at position 28 of Ab numbering by a cysteine
residue (K28C) was shown to be the most effective mutant
in stabilizing APP695 dimers [8], we generated APP K28C
mutants of both isoforms. After transfection of native
CHO-K1 cells with the cysteine mutants, we detected a
slower migrating band at *220 kDa for both APP695
K28C and APP770 K28C under non-reducing conditions
(Fig. 7b), co-migrating at the same molecular weight as
dimers from APP695 ER. Most interestingly, this band
disappeared after boiling the samples with b-mercap-
toethanol (Fig. 7b, ?BME, ?95C), as seen for APP695
ER dimers. These ﬁndings clearly indicated that dimer-
ization of APP retained in the ER is mediated by disulﬁde-
bond formation, since linking of two thiol groups could
only be generated through oxidation in the ER. Further-
more, we demonstrated that it is possible to force lateral
cis-dimerization of APP770. The K28C mutation seems to
be potent enough to overcome a putative sterical hindrance
of the KPI domain, by cross-linking two apposed trans-
membrane domains of APP770. Next, we questioned
whether the artiﬁcial disulﬁde bond, potentially generated
in the ER, might affect APP trafﬁcking and processing
through the secretory pathway. It has been reported pre-
viously by Eggert and colleagues that cysteine substitution
at position 28 of Ab caused a signiﬁcant decrease in sol-
uble cleavage products such as APPsa/b and Ab-peptides
[17]. We therefore analyzed surface levels of APP695
K28C by surface biotinylation (Fig. 7c). Indeed, we could
clearly show that the APP K28C mutant reached the
plasma membrane comparable to APP695 wt (Fig. 7c, right
panel), whereas trafﬁcking of our ER retention mutant was
efﬁciently inhibited. We therefore conclude that dimer-
ization itself does not necessarily interfere with APP
trafﬁcking, nor seems dimerization a prerequisite for
plasma membrane localization.
Fig. 6 CHO-K1 cells stably
overexpressing either APP695
wt or APP695 ER were
transiently co-transfected with
human APLP1 cDNA, or empty
vector pLBCX alone (–). At
24-h post-transfection, cells
were lysed and equal amounts
of total lysates (250 lg) were
immunoprecipitated with either
9E10 antibody (for APP), or
171615 antibody (for APLP1).
Co-puriﬁed proteins were
detected with antibodies as
indicated (IP: APLP1 WB:
9E10 for APP, lower panel; left)
and reverse (IP: 9E10, WB:
APLP1, lower part; right).
Lysate controls were analyzed
with the same antibodies (upper
blots) and Tubulin served as
loading control. Note that
heterointeraction of APP and
APLP1 is increased, when APP
is retained in the ER
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of the APP isoform
As we have shown before, APP770 containing a KPI
domain displayed a weakened tendency for intracellular
cis-dimerization upon ER retention (Fig. 7a) compared to
the neuronal isoform 695. However, in line with previous
ﬁndings [9, 11], we have veriﬁed the E1-domain as the
major dimerization interface of two APP molecules
(Fig. 4). Consequently, we predicted that the presence of
the KPI-domain should not affect intercellular trans-
dimerization properties of APP770 (see illustration in
Fig. 8d). To compare the homophilic trans-cellular
dimerization properties of KPI-containing isoforms versus
APP695, we employed a well-established cell aggregation
assay using Drosophila Schneider (S2) cells, which lack
endogenous expression of the APP homologue APPL [9].
We have previously shown that expression of APP695 and
APLPs in different pools of S2 cells caused signiﬁcant
clustering after mixing of the two cell populations, whereas
cells expressing only GFP did not co-aggregate with APP/
APLP-expressing cells [9]. Thus, cell clustering provides a
direct readout for the speciﬁc interaction of the two pro-
teins, whereas unspeciﬁc interaction of APP/APLPs with
endogenous S2 cell proteins was excluded [9]. Therefore,
we transfected S2 cells with cDNAs encoding all human
APP isoforms (695, 751, 770), or APP695DE1 and ana-
lyzed aggregation via immunocytochemical analysis, as
shown in Fig. 8a. Despite a low transfection efﬁciency
(15%), we observed almost equal clustering ratios for cells
expressing either APP isoform (Fig. 8b), whereas cells
expressing APP695DE1 did not cluster speciﬁcally (Fig 8a,
b), similar to untransfected S2 cells. Furthermore, confocal
microscopy revealed accumulated APP immunoreactivity
Fig. 7 The APP KPI-domain hinders intracellular cis-dimerization in
the ER. a Lysates of CHO-K1 cells, stably overexpressing either
APP695, APP770, or transiently APP751 (both containing a KPI
domain) and the corresponding di-lysine ER retention mutants. SDS-
PAGE under non-reducing conditions and Western blot with 9E10
antibody shows no SDS stable cis-homodimers in the ER for both
KPI-containing isoforms, compared to APP 695 ER. b CHO-K1 cells
were transiently transfected with the K28C mutant (Ab numbering) of
both APP isoforms and run alongside lysates of K1 cells stably
overexpressing APP695, APP770 or the respective ER retention
constructs (APP ER). Cell lysates were analyzed under non-reducing,
versus reducing conditions on 4–12% SDS gels. APP full length,
dimers, and CTFs were immunoblotted with 9E10 antibody. K28C
mutation led to the formation of SDS stable dimers at *220 kDa,
independent of the used APP isoform. Covalent S–S bonds were
dissolved after denaturing the samples with BME at 95C. c CHO-K1
cells stably overexpressing either APP695 wt or APP695 ER, or
transiently overexpressing APP695 K28C, were labeled with sulfo
NHS-SS-biotin and analyzed by SDS-PAGE and Western blot (PD:
NeutrAvidin; right panel). Lysates were used as input control and
APP and its cleavage products (CTFs) were detected with 9E10
antibody. Tubulin veriﬁed equal protein loading or cleanness of the
biotinylation. Note that the artiﬁcial cysteine mutation (K28C) led to
efﬁcient dimerization of APP (Input, left panel). The dimer of APP
K28C migrated as a doublet, revealing two putative glycosylation
patterns (ER and Golgi), because the construct reached the cell
surface. Note that in the biotinylation only the mature APP K28C
appeared at the cell surface
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in line with previously published data [9]. Together, these
results demonstrate that cell–cell interaction by ectodo-
main-mediated adhesion is independent of the presence of
a KPI domain. However, APP dimerization speciﬁcally
depends on E1 domain associations at both the cell sur-
face and within the cell (compare to Fig. 4). In our
studies, only APP695 was able to form lateral intracel-
lular (in the ER) as well as intercellular trans-dimers (at
the cell surface). However, the KPI domain of the longer
isoforms hindered lateral cis-interaction but not homo-
philic trans-interaction (Fig. 8d, schematic drawing),
because the E1 domains of two molecules can still
dimerize.
Fig. 8 APP trans-dimerization
at the cell surface is not
inﬂuenced by the KPI domain.
a Immunostainings of S2 cells
transiently expressing human
APP of either isoform 695, 751,
770, or APP695DE1 were
stained by anti APP antibody
(CT-20) and secondary anti-
rabbit AlexaFluor488. Note that
untransfected- or APP695DE1
expressing cells do not
aggregate. b Quantiﬁcation of
clustered cells is shown.
Transfected cells were counted
and relative amount of
aggregated cells is shown
(n C 3, ± SD) and statistical
signiﬁcance **p\0.05, t test.
Note that expression of either
APP isoform caused equal
homotypic clustering of S2
cells. Scale bar equals 20 lm.
c A single confocal section
homotypic aggregated S2 cells
is shown. Scale bar equals
5 lm. d Hypothetical model
depicting dimerization
properties of APP isoforms
within different cellular
compartments. APP695 isoform
can form homodimers in the ER
lumen, favored by oxidizing
conditions. However, APP770
failed to dimerize in the same
manner, possibly due to the
presence of a KPI domain which
might adopt an inhibitory,
intramolecular structure thereby
impeding cis-directed
homodimerization. At the
surface of Drosophila S2 cells
dimerization can occur
independent of the particular
APP isoform in trans-direction
(right panel)
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In our study, we aimed to elaborate the putative dimeriza-
tion potential of APP in different cellular locations, and
deﬁne the precise origin of APP dimer formation. We
employed a cell culture model overexpressing APP chi-
meric proteins with C-terminal double-lysine retention
motifs, previously described to retain type I transmembrane
proteins in early secretory compartments [20–22]. On SDS-
PAGE, KKXX-tagged APP chimeras migrated exclusive as
immature species, lacking Golgi-speciﬁc carbohydrate
modiﬁcations, whereas APP wild-type appeared as a set of
two bands, equivalent to N-and O-glycosylated forms
(Fig. 1b). However, most interestingly we found an explicit
upper migrating band for APP695 when it was retained
in the ER by the KKAA motif. Strikingly, this band
co-migrated at the expected molecular weight of a putative
APP dimer (*220 kDa), which remained stable upon SDS
treatment, but progressively disappeared under strong
reducing conditions (Fig. 1c, d), suggesting that disulﬁde-
linked APP dimers can exist in cells. This was conﬁrmed
using various tagged APP species (myc/HA), excluding that
the upper SDS-stable band resulted from unspeciﬁc aggre-
gation with cellular proteins, other than APP itself (Fig 4b).
Moreover, we detected no SDS-stable dimers with our
experimental conditions when APP was shuttled between
ER and Golgi compartment due to the KKFF ER-exit-
determinant. We therefore believe that there exists an APP
monomer-to-dimer equilibrium, which may vary in differ-
ent cell compartments, or possibly depends on the redox
state of a given cell. Moreover, we could demonstrate that
once generated in the ER, dimers persisted stable through-
out transport, and reached the plasma membrane (Fig. 3d),
verifying that they occur normally in the cell. Our hypoth-
esis that APP originally dimerizes in the ER was further
strengthened by split GFP experiments. Thus, two non-
ﬂuorescent GFP fragments fused individually to the C-ter-
mini of APP, assembled into dimers to form a ﬂuorescent
signal, when co-localized with a speciﬁc ER marker Grp78
(Fig. 3a–c). However, under normal cellular conditions the
portion of disulﬁde linked dimers might be too less to
capture them on Western blots. Therefore, our cell culture
model exempliﬁed APP dimerization as it might occur
under different cellular conditions, particularly visualizing
dimerization itself, and thus identifying the ER as the sub-
cellular compartment of its origin, where ideal oxidizing
conditions might favor disulﬁde bond formation between
APP molecules [42, 43]. Besides other proposed mecha-
nisms for APP dimerization [10, 12], we believe that
intermolecular disulﬁde linkage, between cysteines located
in the E1 domain, represents another mechanism of how at
least an APP sub-fraction can dimerize. Indeed, deleting
either the E1 domain or the entire N-terminal part (C99, not
shown) abolished APP homodimers in our system (Fig. 4c),
indicating that this region of the APP ectodomain is indis-
pensable for homointeraction, conﬁrming previously
reported results [9, 11]. Interestingly, serine substitution of
cysteines at positions 98 and 105, embedded in the con-
served loop region within the E1 domain [10, 41], interfered
with SDS-stable dimer formation in the ER (Fig. 4d). This
indicated that at least one of the respective cysteines might
be essential for intermolecular disulﬁde formation. How-
ever, this does not exclude the existence of different dimer
species, e.g., driven by hydrophobic interactions between
the transmembrane domains of two proximal APP mole-
cules [12–14]. Interestingly, other research efforts have
focused on the juxtamembrane (JM) and transmembrane
(TM) region, where APP contains three GxxxG motifs [44].
Originally, this motif was shown to mediate close apposi-
tion and dimerization of membrane proteins such as
glycophorin A (GpA) [45, 46], whereby hydrogen bonds
stabilize the helical conformation of transmembrane span-
ning domains, allowing short interhelical axial distances
between two segments in a membrane environment [46].
Recent mutational studies revealed that the GxxxG motifs
in the APP TM domain might also participate in C99/bCTF
dimerization [12, 14], although their impact on dimerization
is still a matter of debate. For example, Munter and col-
leagues found that the ability of the APP TM sequence to
dimerize in a bacterial membrane system (ToxR assays)
was diminished, when central glycine residues, Gly29 and
Gly33, were substituted by bulkier amino acids, thus
modulating Ab production [12]. Unexpectedly, studies in
CHO (mammal) cells indicated that the mutation of the
central glycine residues to bulky isoleucine seemed to allow
dimerization of the entire C99 protein in cell lines, whereas
pairwise replacement with leucines even enhanced the
formation of SDS-stable C99 dimers, instead of weakening
interaction [14], contradicting previous reported results.
Nevertheless, in both studies, mutation of the GxxxG motifs
led to a drastic reduction of Ab42 secretion [12, 14]. In
agreement with the existing experimental data [12, 14],
molecular dynamics simulation of two APP fragments
(Ab23-55) in a membrane environment, for both the wild-
type GxxxG sequence and the leucine mutant, revealed that
the c-site in the mutant was shifted towards the center of the
membrane, which would reduce the secretion of Ab40 and
Ab42 [47]. However, considering that no intermolecular
disulﬁde chains can be involved in C99 oligomerization (no
cysteines present), as seen by Kienlen-Campard et al., we
speculate that dimerization of APP TM helices is not nec-
essarily taking place in the ER. Thus, probably serving as a
prerequisite to accomplish close apposition of two APP full-
length molecules, facilitating interactions between E1
domains. Since our studies are primarily based on the APP
full-length protein in a cellular context, we do not exclude
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mediate dimerization between two proximal TM helices of
APP. While we did not identify the formation of stable C99
dimers, irrespective or ER retention or not (data not shown),
this might be also cell-speciﬁc or dependent on the structure
and the composition of the bilayer in which it is anchored
[12–14].
To gain further insight into dimerization properties of
APP, we investigated whether we might observe a similar
mechanism with one of its homologues. It has been
recently shown by Kaden and colleagues that APP and
APLP1 exhibit strikingly different subcellular localiza-
tions, with APP being distributed more intracellularly and
APLP1 mainly localized to the cell surface [11]. Due to
this different cellular distribution, we were curious whether
APP might have a retentive inﬂuence over APLP1, likely
by forming heterodimers as early as in the ER. Indeed,
surface biotinylation experiments revealed that APP was
able to retain a portion of APLP1 in the ER, consequently
preexisting APP homodimers were diminished whereas an
increase in monomers was observed (Fig. 5). Additionally,
co-immunoprecipitations conﬁrmed an increased interac-
tion between both homologues, when APP was retained in
the ER (Fig. 6). Most interestingly, we detected the for-
mation of SDS-stable APP/APLP1 heterodimers,
suggesting an equivalent mechanism for heterodimer for-
mation, likely involving disulﬁde bond(s). Therefore we
provide ﬁrst evidence that it was possible to visualize a
beginning dimer formation between both homologues early
in the secretory pathway. This was particularly interesting,
due to the fact that hetero-complex formation between APP
and APLPs was shown to diminish Ab production.
Therefore, the ER might provide an interesting target
possibly favoring dimer equilibrium from homo- to hetero-
complexes, thus inﬂuencing Ab generation.
Since all studies so far have predominantly focused on
the dimerization properties of APP695 lacking the KPI
domain, we analyzed if the longer isoforms interact in the
same manner as APP695. Due to the fact that the KPI
domain encompasses six further cysteine residues, in
addition to the 12 cysteines already present in the E1
domain, one could imagine an increased dimerization
potential by disulﬁde linkage. Surprisingly, when APP770
or APP751 were retained in the ER, no cis-directed
homodimer formation was observed on Western blots
(Fig. 7a). In contrast, we were able to induce cis-dimer-
ization of APP770 using a previously described [8, 17]
constitutive dimerization mutant (APP770 K28C). This led
us to the assumption that the KPI might somehow exhibit a
sterical obstruction, possibly diverging two E1 domains
thus interfering with dimerization. Nevertheless, the close
proximity of two APP TM domains might be sufﬁcient to
cross-link the full-length proteins by the constitutive K28C
mutant (Fig. 7b, c). Interestingly, this cysteine mutant also
reached the cell surface (Fig. 7c), yet the disulﬁde bond
can only be formed in the ER via oxidation, conﬁrming our
hypothesis that once generated, covalent dimers are traf-
ﬁcked normally in the cell (compare to Fig. 3d, e).
Moreover, this suggested close apposition between APP
molecules, or else this constitutive disulﬁde bond could
never been generated via oxidation in the ER.
Having demonstrated that dimer formation of KPI-APP
seemed less efﬁcient in the ER, but was induced by an
engineered disulﬁde bond, we questioned whether APP
isoforms might also display diverse trans-dimerization
capacities at the surface, affecting cell adhesion. We
employed a well-described cell aggregation assay in Dro-
sophila Schneider (S2)-cells, previously established by
Soba et al., where they could demonstrate that APP695 can
form homo-as well as hetero-complexes with APLPs at the
surface of different cells [9]. However, expression of all
three different APP isoforms in S2-cells led to equal cell
clustering (Fig. 8), whereas the absence of the extracellular
E1 domain abolished speciﬁc aggregation of transfected S2
cells (Fig. 8a, b), consistent with observations by Soba and
colleagues. Therefore, we speculate that the KPI domain
might hinder exclusively cis-dimerization of APP within
the same cell, whereas trans-dimers at the surface of two or
more cells, were unperturbed (see illustration in Fig. 8d).
These ﬁndings raised the question: how can the differences
in cis/trans interactions between isoforms be explained?
Interestingly, it has recently been shown by small-angle
X-ray scattering (SAXS), a method to deduce high-reso-
lution, three-dimensional protein structures, that a domain
likely corresponding to the KPI domain of APP770 emer-
ges laterally from one end of the molecule, and is freely
exposed on the APP surface [48, 49]. Therefore, it is
tempting to speculate that the KPI domain might adapt
different structural features, possibly depending on the
redox state, maintained in a subcellular compartment/
microdomain. It seems possible that the six cysteine resi-
dues present in the KPI domain [50] could lead to a
different folding through the formation of intramolecular
disulﬁde bonds [39] in the ER, but not at the cell surface.
Consequently, such conformational changes might poten-
tially hinder dimerization of two adjacent APP molecules
only in cis-direction (Fig. 7, 8). In contrast, APP trans-
dimerization seemed less sterical obstructed by the pres-
ence of the KPI domain, since opposed E1 domains can
still interact (see hypothetical illustration in Fig. 8d). While
it was possible to force lateral cis-dimerization by intro-
ducing an artiﬁcial cysteine bond at the TM border of APP
(K28C), irrespective of a KPI domain, we speculate that
the vicinity of two molecules (or TM helices), is crucial for
cis-dimerization [12]. If two APP molecules reside in close
proximity within the same membrane, the redox state of the
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idues of the E1 domain, or likewise by an engineered
disulﬁde bond. Nevertheless, we assume that trans-dimer-
ization in this aggregation assay is primarily established by
hydrophobic interactions, instead of S–S bonds, since cell
surface PDI has so far only been identiﬁed in few cell
types, shown to modify disulﬁde bonds, e.g., in b-integrins,
thus regulating adhesion and migration [51].
In conclusion, our results provide novel observations
for the regulation of APP dimerization. To date, the
physiological signiﬁcance of APP–APP interactions has so
far remained elusive, but it has been well described that in
mammalian cells, the most common mechanism of signal
transduction for single-pass transmembrane proteins
occurs through a shift in the monomer–dimer equilibrium
[52]. Since APP resembles a cell surface receptor,
dimerization and dissociation might also regulate various
APP functions. One could imagine that cell-bound APP
could form dimers in trans-regulating cell–cell adhesion,
whereas cis-dimerized APP could act as a growth factor
receptor when it is localized to the same cell membrane.
In our study, we could demonstrate that APP already di-
merizes early in the secretory pathway, within the ER,
suggesting that at least a fraction of APP may exist as
covalent-associated disulﬁde dimers, before being trans-
ported to the plasma membrane. Therefore this might
serve as prerequisite for its correct orientation and expo-
sure to the cell surface, and if APP can be transported
once to the cell surface as a dimer, it may achieve the
status of a cell surface receptor [53]. Furthermore, we
describe a novel mechanism of how APP can form inter-
molecular dimers. We provide strong evidence that
disulﬁde bridges formed in the ER facilitate cis-dimer-
ization of APP695 within the same cell, whereas KPI-APP
seemed to exhibit different dimerization capacities in the
ER, but not in trans-direction at the plasma membrane.
Moreover, our data might suggest a related mechanism for
heterodimer formation of APP, with at least one homo-
logue, APLP1. Nevertheless, further experimental
evidence is needed. Taken together, dynamic alterations of
APP between monomeric, homodimeric, and possibly
heterodimeric status could at least partially explain some
of the variety in the functions of APP. However, as our
analysis focused on the full-length cellular APP proteins
and not on isolated domains, dimerization properties might
vary between different cell systems or experimental set-
ups, not excluding the co-existence of diverse dimerization
mechanisms in the same cell.
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